Top Markets
#1 Nesa Nesa +795.86%
#2 Cortex Cortex +68.55%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.65%
#4 QuantixAI QuantixAI +23.51%
#5 EXOD EXOD +22.78%
#6 Pons Pons +21.61%
#7 OpenEden OpenEden +17.10%
#8 Instadapp Instadapp +16.15%
#9 Magma Finance Magma Finance +12.82%
#10 Movement Movement +12.38%
Coin of the day
Nesa Nesa
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Connect Biopharma Holdings Limited Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTB
Clasificación en acciones #19732
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical... Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
Precio por acción
$2.42
Última sincronización: 2026-08-25
Capitalización bursátil
$152.37M
Cambio (1 día)
5.22%
Cambio (1 año)
39.88%
País
US
Comercio Connect Biopharma Holdings Limited (CNTB)

Categoría

Healthcare
Historial del precio de la acción de Connect Biopharma Holdings Limited (CNTB)
Precio más alto de cierre: $2.35 el 2026-08-01

Precio más bajo de cierre: $17.02 el 2021-03-01
Historial del precio de la acción de Connect Biopharma Holdings Limited desde 2021 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -8.60%
2025 129.78%
2024 18.63%
2023 21.12%
2022 -83.36%
2021 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.16 -12.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH